In the case of hepatic insulin resistance, insulin fails to suppress HGP but stimulates lipogenesis, which results in hyperglycemia, hyperlipidemia, and hepatic steatosis [39]
With this in mind, ideal candidates tend to include: Adults with a body mass index (BMI) above the healthy range Individuals who have struggled to lose weight through diet and exercise alone Adults seeking to reduce appetite and portion sizes naturally Individuals looking to prevent or manage weight-related health risks Patients who prefer a gradual, medically guided approach to weight loss Those in good general health with realistic expectations While GLP-1s appeal to a wide range of potential candidates, your eligibility will be established during your personal consultation with Dr
Supplements provide nutrients but dont have the same direct metabolic reprogramming effects
Market Segmentation By Drug Type: By Indication: By Route of Administration: By End User: Regional Insights North America holds the largest market share due to high disease prevalence, early adoption of novel therapies, and robust healthcare infrastructure
Although quantitative data on GLP-1 misuse among eating disorder populations are lacking, anecdotal reports suggest rising incidence
Chelation therapy is a potential treatment option as it binds to excess metals, facilitating their removal from the body
